Tan et al. demonstrated that the combination of r-tPA (tissue plasminogen activator) and APT102 reduces mortality rate, decreases infarct volume, and improves neurological deficit scores as well as prevents r-tPA-induced hemorrhage transformation in the experimental stroke model [111]. This evidence concerns the gene PLAT and Stroke.